Telemedycyna Polska S.A.
0.40
PLN
+0.02
(+6.38%)
ISIN
PLTLMDC00018
Return %
Stock
S&P 500
1Y
-36.51
14.20
3Y
-66.67
81.12
5Y
-71.73
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Maria Lapinska
- Full Time Employees
- 13
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Katowice Poland
- Website
- telemedycynapolska.pl
- Similar Companies
- Business
- Telemedycyna Polska S.A. is a Poland-based healthcare technology and digital health provider specializing in remote medical diagnostics, telecardiology, and comprehensive telecare services. Founded in 2005 and headquartered in Katowice, Poland, the company operates as a publicly traded entity on the Warsaw Stock Exchange NewConnect alternative trading system under the ticker symbol TMP. Telemedycyna Polska S.A. delivers digital health infrastructure and remote monitoring solutions across Poland, serving individual patients, hospitals, outpatient medical clinics, public institutions, private healthcare networks, corporate employers, and insurance operators through its proprietary, round-the-clock medical operations infrastructure, the 24/7 Telemedicine Center. The company operates through diversified e-health service lines categorized into specialized diagnostic and monitoring solutions: Telecardiology Services, comprising the Kardiotele remote cardiac event monitoring platform; 12-lead remote electrocardiogram (ECG) transmission and interpretation; continuous 24-hour and multi-day Holter ECG monitoring with certified physician analysis; and digital triage for cardiac rhythm disorders; Senior Telecare and Remote Safety Solutions, comprising personal emergency response systems (PERS), wearable SOS distress wristbands, GPS location tracking, and 24/7 emergency dispatch coordination for elderly and chronic-care patients; Sleep Medicine Diagnostics, comprising home-based screening, diagnostic testing, and remote telemonitoring for obstructive sleep apnea (OSA); Institutional Healthcare Solutions, comprising outsourced teleconsultation desks, remote diagnostic support for emergency departments and regional clinics, and medical data integration systems; and Corporate Wellness and Occupational Health Services, comprising employee health screening programs, on-site and remote cardiovascular risk assessments, preventive diagnostic days, and health promotion campaigns. In recent corporate developments, Telemedycyna Polska S.A. has executed a comprehensive operational and strategic restructuring aimed at optimizing cost structures, enhancing operating margins, and restoring sustainable revenue growth. As part of this transition, the company restructured its executive leadership with the appointment of a new management board led by Chief Executive Officer Paweł Niedbała to spearhead financial recovery and operational modernization. Strategically, the company has accelerated the integration of artificial intelligence (AI) and automated analytical algorithms into its ECG signal processing pipeline to improve diagnostic speed and clinical scalability. In addition, Telemedycyna Polska S.A. continues to expand its institutional footprint through major clinical research partnerships, including collaborative remote cardiac monitoring projects alongside American Heart of Poland S.A. funded in cooperation with the Polish Medical Research Agency (Agencja Badań Medycznych).